(Q37313420)

19 August 2017

1 reference

title

Skin manifestations of lyme borreliosis: diagnosis and management (English)

1 reference

19 August 2017

0 references

0 references

Robert R Müllegger

1

1 reference

PubMed ID

18973402

19 August 2017

Martin Glatz

series ordinal

2

1 reference

19 August 2017

1 January 2008

1 reference

American Journal of Clinical Dermatology

19 August 2017

1 reference

19 August 2017

9

1 reference

19 August 2017

6

1 reference

19 August 2017

355-368

1 reference

https://scigraph.springernature.com/pub.10.2165/0128071-200809060-00002

19 August 2017

0 references

cites work

The early clinical manifestations of Lyme disease

1 reference

https://api.crossref.org/works/10.2165%2F0128071-200809060-00002

Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0128071-200809060-00002

European Lyme borreliosis: 231 culture-confirmed cases involving patients with erythema migrans

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0128071-200809060-00002

Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0128071-200809060-00002

Lyme disease: recommendations for diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0128071-200809060-00002

Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0128071-200809060-00002

Western blotting in the serodiagnosis of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0128071-200809060-00002

Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0128071-200809060-00002

Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0128071-200809060-00002

Comparison of Cefuroxime Axetil and Doxycycline in the Treatment of Early Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0128071-200809060-00002

Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0128071-200809060-00002

Treatment of the Early Manifestations of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0128071-200809060-00002

Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0128071-200809060-00002

10.2165/0128071-200809060-00002

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

18973402

Dimensions Publication ID

19 August 2017

0 references

1 reference

PubMed ID

18973402